K

Karma Biotechnologies

13 employees

Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.

Basic info

Industry

biotechnology research

Sectors

Cellular Engineering
Biotechnology
Autoimmune Disease
Immunooncology
Gene Editing
Nanotechnology
Tissue Engineering

Date founded

2017

Funding rounds raised

Total raised

$2.8M

from 12 investors over 12 rounds

K

Karma Biotechnologies raised undisclosed on May 31, 2023

Investors: SOSV - The Accelerator VC

K

Karma Biotechnologies raised $2.8M on September 1, 2021

Investors: Calm Ventures, MarsBio, Viva BioInnovator, -, Tuesday Capital, Khosla Ventures and SOSV - The Accelerator VC

K

Karma Biotechnologies raised $2.1M on September 3, 2019

Investors: Khosla Ventures, SOSV - The Accelerator VC, Presight Capital and Tuesday Capital

FAQ